000 01818 a2200469 4500
005 20250518091025.0
264 0 _c20210111
008 202101s 0 0 eng d
022 _a1478-6362
024 7 _a10.1186/s13075-020-2126-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMease, Philip
245 0 0 _aInhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial.
_h[electronic resource]
260 _bArthritis research & therapy
_c03 2020
300 _a43 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntirheumatic Agents
_xadministration & dosage
650 0 4 _aArthritis, Psoriatic
_xdiagnostic imaging
650 0 4 _aDisease Progression
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHand Joints
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRadiography
_xmethods
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Outcome
700 1 _aHusni, M Elaine
700 1 _aKafka, Shelly
700 1 _aChakravarty, Soumya D
700 1 _aHarrison, Diane D
700 1 _aLo, Kim Hung
700 1 _aXu, Stephen
700 1 _aHsia, Elizabeth C
700 1 _aKavanaugh, Arthur
773 0 _tArthritis research & therapy
_gvol. 22
_gno. 1
_gp. 43
856 4 0 _uhttps://doi.org/10.1186/s13075-020-2126-1
_zAvailable from publisher's website
999 _c30714302
_d30714302